Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 35, pseudogene (abbreviated as RN7SL35P) is classified as a pseudogene of 7SL RNA, a non-coding RNA component that is crucial in the function of the signal recognition particle (SRP)[4][3][7]. Unlike functional 7SL RNA genes, the majority of such pseudogenes, including RN7SL35P, do not produce functional SRP RNA molecules, as they are typically truncated or otherwise nonfunctional copies resulting from retrotransposition events[3][7]. While most pseudogenes are considered nonfunctional, recent research suggests that some pseudogenes may be transcribed and can exert regulatory effects, such as acting as miRNA sponges or influencing expression of their parental genes via non-coding RNA mechanisms, though there is no direct evidence for these roles in RN7SL35P specifically[6]. There are no reported drug or biomarker associations, and this pseudogene is not regarded as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 35, pseudogene (RN7SL35P).